Practical implication
Review current compliance workflows and adjust processes for monitoring imports under the new packaging rules.
The Australian Government has updated the Personal Importation Scheme to aid authorities in identifying imported therapeutic goods and to minimize the risks of unidentified, mislabelled, or counterfeit products entering Australia.
What changed: Changes to the Personal Importation Scheme were implemented, affecting how imported therapeutic goods are packaged and identified.
Why it matters: These changes could significantly impact local pharmacovigilance compliance efforts and improve the safety of therapeutic goods within Australia.
Practical implication: Review current compliance workflows and adjust processes for monitoring imports under the new packaging rules.
View original source
- Source: TGA Safety Alerts - Media releases feed
- Published at source: 2026-09-08T00:00:00.000Z
- Discovered by monitor: 2026-09-08T21:18:33.375Z
Published from the regulator source ingestion pipeline after PV impact triage.